Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C F Pollera

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
European Journal of Cancer & Clinical Oncology|February 1, 1984
Randomized open cross-over trial between metoclopramide (MCP) and dexamethazone (DXM) for the prevention of cisplatin-induced nausea and vomitingF Cognetti, P Pinnarò, P Carlini, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1984
Improved control of cisplatin-induced emesis with a metoclopramide-dexamethasone combinationF Cognetti, P Pinnaro, P Carlini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 2, 1999
Does pain at tumor site during vinorelbine infusion affect treatment of recurrent head and neck cancer patients?S De Marco, A Fabi, A Ceribelli, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1987
Changes in serum iron levels following very high-dose cisplatinC F Pollera, F Ameglio, S Reina, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1990
Intraperitoneal recombinant alpha-2-interferon alternating with cisplatin as salvage therapy for minimal residual-disease ovarian cancer: a phase II studyM Nardi, F Cognetti, C F Pollera, et al.
Cancer Investigation|January 1, 1994
High dose-intense chemotherapy alone or in combination with interleukin-2 for small cell lung cancer: a pilot studyC F Pollera, F Calabresi, M Moreschi, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1996
A combination of ifosfamide and mitoxantrone as salvage therapy in patients with advanced ovarian cancerM Nardi, M Della Giulia, C F Pollera, et al.
European Journal of Cancer (Oxford, England : 1990)|December 16, 1998
A phase II study of gemcitabine in patients with transitional cell carcinoma of the urinary tract previously treated with platinum. Italian Co-operative Group on Bladder CancerV Lorusso, C F Pollera, M Antimi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 24, 2011
Adjuvant chemotherapy with cisplatin and gemcitabine versus chemotherapy at relapse in patients with muscle-invasive bladder cancer submitted to radical cystectomy: an Italian, multicenter, randomized phase III trialF Cognetti, E M Ruggeri, A Felici, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
European Journal of Cancer & Clinical Oncology|February 1, 1984
Randomized open cross-over trial between metoclopramide (MCP) and dexamethazone (DXM) for the prevention of cisplatin-induced nausea and vomitingF Cognetti, P Pinnarò, P Carlini, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1984
Improved control of cisplatin-induced emesis with a metoclopramide-dexamethasone combinationF Cognetti, P Pinnaro, P Carlini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 2, 1999
Does pain at tumor site during vinorelbine infusion affect treatment of recurrent head and neck cancer patients?S De Marco, A Fabi, A Ceribelli, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1987
Changes in serum iron levels following very high-dose cisplatinC F Pollera, F Ameglio, S Reina, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1990
Intraperitoneal recombinant alpha-2-interferon alternating with cisplatin as salvage therapy for minimal residual-disease ovarian cancer: a phase II studyM Nardi, F Cognetti, C F Pollera, et al.
Cancer Investigation|January 1, 1994
High dose-intense chemotherapy alone or in combination with interleukin-2 for small cell lung cancer: a pilot studyC F Pollera, F Calabresi, M Moreschi, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1996
A combination of ifosfamide and mitoxantrone as salvage therapy in patients with advanced ovarian cancerM Nardi, M Della Giulia, C F Pollera, et al.
European Journal of Cancer (Oxford, England : 1990)|December 16, 1998
A phase II study of gemcitabine in patients with transitional cell carcinoma of the urinary tract previously treated with platinum. Italian Co-operative Group on Bladder CancerV Lorusso, C F Pollera, M Antimi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 24, 2011
Adjuvant chemotherapy with cisplatin and gemcitabine versus chemotherapy at relapse in patients with muscle-invasive bladder cancer submitted to radical cystectomy: an Italian, multicenter, randomized phase III trialF Cognetti, E M Ruggeri, A Felici, et al.
Pageof 3